View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
March 26, 2020

Covid-19 pandemic pushes pharma sales reps deeper into the virtual space

By GlobalData Healthcare

As the Covid-19 pandemic continues to spread globally, pharmaceutical companies are experiencing the shift towards working from home, which has various impacts on the industry, with the most notable one being an increasing trend in the use of virtual meetings and digital sales tools. The shift from in-person to digital is seen in advertising, medical conferences, and sales rep meetings with physicians. GlobalData believes that virtual platforms will experience an extra boost after already having a transformational impact on the entire healthcare landscape even before the Covid-19 pandemic.

Free Whitepaper
img

What is the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China’s adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022’s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China’s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData’s new whitepaper, China in 2022: the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:
  • Which multinational companies have been affected?
  • What is the effect of lockdowns on foodservice?
  • What is the effect of lockdowns on Chinese ports?
  • Spotlight on Shanghai: what is the situation there?
  • How have Chinese consumers reacted?
  • How might the Chinese government react?
  • What are the potential growth opportunities?
by GlobalData
Enter your details here to receive your free Whitepaper.

Over the past years, the pharma world has seen the increasing use of video calls, health management mobile apps, text messaging, sensors, and social media. Virtual health tools are already there enabling companies to have broader engagement with patients and physicians throughout various phases of the patient journey. Sales forces from pharma companies are now using this technology, even more, to interact virtually with physicians, particularly during the Covid-19 outbreak.

Teledetailing, also referred to as ‘e-detailing’ or ‘remote detailing,’ is an interactive, online, real-time meeting between a sales rep and a healthcare professional. This type of virtual meeting has been used increasingly by pharma reps because it has many advantages, such as the fact that doctors value brief and effective conversations, reps can reach target groups quickly and effectively, and overall this method is extremely cost-effective. However, in-person meetings have their own advantages, such as people being able to express themselves by using body language and facial expressions that can better convey a message and create a deeper bond with a customer.

As the Covid-19 pandemic sees cancellations of clinical events and conferences as well as a surge of virtual meetings while all face-to-face contacts halt, the lack of a physical component in human interaction may lead to the weaker influence of reps over respective physicians and therefore reduced drug sales. Nevertheless, the ever-increasing internet speed, with 5G on our doorstep, as well as the evolving video conferencing software, such as WebEx, Zoom, or Skype for Business, will somewhat alleviate these problems.

Over the past decade, our lifestyles have been becoming more and more reliant on digital tools, and human interactions have been increasingly coming under threat. It remains to be seen whether the current extraordinary and testing circumstances will push humanity further into virtual space with little hope to go back to where we were before the pandemic struck. The pharma sales forces and physicians may get used to the new reality, and thus the use of the virtual meetings and tools may get boosted far beyond the pandemic.

Related Companies

Free Whitepaper
img

What is the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China’s adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022’s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China’s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData’s new whitepaper, China in 2022: the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:
  • Which multinational companies have been affected?
  • What is the effect of lockdowns on foodservice?
  • What is the effect of lockdowns on Chinese ports?
  • Spotlight on Shanghai: what is the situation there?
  • How have Chinese consumers reacted?
  • How might the Chinese government react?
  • What are the potential growth opportunities?
by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology